- A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the International Oncology Study Group CML1 study. Giles, F.J., Shan, J., Chen, S., Advani, S.H., Supandiman, I., Aziz, Z., Caviles, A.P., Tee, G.Y., Chasen, M.R., Fahed, Z., Chaoj, T.Y., Aydogdu, I., Lynott, A.M. Leuk. Lymphoma (2000)